Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
BitVulpex.pro Launches Proof of Reserves System to Strengthen Transparency, Security, and User Trust
Inside the Team Steering the Next Chapter of Lululemon’s Design Strategy
Beauty’s Favourite Celebrity Face: One That’s Not Everywhere
Oil returns above $90 as Iran hits tankers
Allbridge pauses cross-chain bridge after $1.65M exploit
Spain outplay Messi’s Argentina to reach World Cup summit
Japanese logistics company eyes JPYC stablecoin to pay drivers
Sudoku 7,388 easy
Quick crossword No 17,536
ITV political editor found it ‘too difficult’ returning to Wales after wife’s death
Oman’s quarterly hotel revenues rise 8.4% to OMR85.4 million
Best Power Banks (2026): My Picks After Testing Over 100
How to Disable Music Videos in Spotify
Stable summer trading expected across UK’s inbound visitor economy
Bruno Mars has an unexpected opening before Wembley party starts
South African Barefoot Footwear Brand Common Tread Launches in the United States
Former Corporate Banking Executive and Broker Launches AI Software That Underwrites Deals AND Matches to the Right Lender From 15,000+ Capital Sources in Seconds
Whnas Advances Global Financial Services and Ecosystem Development
BAIC Off-road Flagship TAITAN700 Debuts, Set to Challenge the Luxury Off-Road Market
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute